{"id":"mmi","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Orthostatic hypotension"}]},"_chembl":null,"_fixedAt":"2026-03-30T18:00:00.794788","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting MAO-B, MMI reduces the breakdown of dopamine in the brain, increasing its availability and potentially alleviating symptoms of Parkinson's disease.","oneSentence":"MMI is a selective monoamine oxidase B (MAO-B) inhibitor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:39.759Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parkinson's disease"}]},"_fixedFields":["pubmed(2569)"],"trialDetails":[{"nctId":"NCT06180486","phase":"NA","title":"Mindfulness Meditation Intervention Study","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2024-02-02","conditions":"Total Knee Replacement, Mediation, Feasibility","enrollment":30},{"nctId":"NCT07109466","phase":"NA","title":"Targeting the Hip Abductors to Reduce Falls in Older Veterans Through A Virtual Multimodal Balance Intervention","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Falls","enrollment":110},{"nctId":"NCT03593473","phase":"PHASE2","title":"Inhaled Oxytocin and HPA Axis Reactivity","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-02-07","conditions":"Depression, Postpartum, Anxiety Disorders, Stress, Psychological","enrollment":109},{"nctId":"NCT07040306","phase":"","title":"A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China","status":"RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2012-11-14","conditions":"Graves´ Disease","enrollment":1000},{"nctId":"NCT06240455","phase":"PHASE2","title":"Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz","status":"SUSPENDED","sponsor":"Worg Biotherapeutics Inc.","startDate":"2026-03-31","conditions":"Graves Disease","enrollment":176},{"nctId":"NCT05118932","phase":"NA","title":"Examining Effects of Holistic School Enrichment Programs","status":"COMPLETED","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2017-05-22","conditions":"Mindful Movement Intervention (MMI)","enrollment":196},{"nctId":"NCT06570967","phase":"","title":"A Clinical Study of Hyperthyroidism in Children","status":"RECRUITING","sponsor":"Shengjing Hospital","startDate":"2023-07-18","conditions":"Hyperthyroidism","enrollment":1000},{"nctId":"NCT06540469","phase":"NA","title":"Iodine Supplementation in Graves' Hyperthyroidism","status":"NOT_YET_RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2024-08-01","conditions":"Graves Disease, Hyperthyroidism","enrollment":315},{"nctId":"NCT01465490","phase":"PHASE1, PHASE2","title":"Monitoring and Feedback in Substance Abuse Treatment","status":"COMPLETED","sponsor":"Treatment Research Institute","startDate":"2007-09","conditions":"Substance Abuse","enrollment":327},{"nctId":"NCT04776993","phase":"PHASE3","title":"A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy","status":"UNKNOWN","sponsor":"University of Pisa","startDate":"2023-03-02","conditions":"Graves' Orbitopathy","enrollment":52},{"nctId":"NCT05043233","phase":"","title":"Observation in the Treatment of Graves' Disease","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-10-01","conditions":"Patient Acceptance of Health Care","enrollment":1000},{"nctId":"NCT02583932","phase":"PHASE3","title":"Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer","status":"COMPLETED","sponsor":"Jewish General Hospital","startDate":"2015-10","conditions":"Advanced Cancer","enrollment":179},{"nctId":"NCT01794559","phase":"NA","title":"Study to Evaluate the Safety and Efficacy of PEER Interactive Versus Treatment as Usual in Subjects With a Primary Diagnosis of Depression","status":"SUSPENDED","sponsor":"MYnd Analytics","startDate":"2013-03-01","conditions":"Depressive Disorder","enrollment":1922},{"nctId":"NCT01693991","phase":"PHASE1","title":"Randomized Controlled Trial of the Meaning-Making Intervention (MMi)","status":"COMPLETED","sponsor":"Jewish General Hospital","startDate":"2012-10","conditions":"Advanced Cancer","enrollment":60},{"nctId":"NCT00917241","phase":"PHASE4","title":"Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone","status":"COMPLETED","sponsor":"Xiao-Ming Mao","startDate":"2004-06","conditions":"Graves' Disease","enrollment":218},{"nctId":"NCT01607684","phase":"PHASE2","title":"Pilot Study to Evaluate Magnetic Marker Imaging on Diabetic Polyneuropathy and Gastroparesis","status":"COMPLETED","sponsor":"Martin-Luther-Universität Halle-Wittenberg","startDate":"2012-01","conditions":"Diabetic Polyneuropathy, Diabetic Gastroparesis, Diabetes Mellitus","enrollment":50},{"nctId":"NCT01565213","phase":"PHASE3","title":"Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2006-01","conditions":"Anxiety Disorders, Depressive Disorders, Stress Disorders","enrollment":245}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"CONTUSION"},{"count":1,"reaction":"COVID-19"},{"count":1,"reaction":"HYPOCALCAEMIA"},{"count":1,"reaction":"HYPOTHYROIDISM"},{"count":1,"reaction":"RECALLED PRODUCT"}],"_approvalHistory":[],"publicationCount":2569,"recentPublications":[{"date":"2026 Mar 27","pmid":"41905467","title":"MAD-score: a Prognostic Model for Malignant Middle Cerebral Artery Infarction Patients Treated with Decompressive Craniectomy.","journal":"World neurosurgery"},{"date":"2026 Mar 23","pmid":"41875586","title":"Using genus-level taxonomy and traits to develop diatom multimetric indices to assess wetland condition across the conterminous United States.","journal":"The Science of the total environment"},{"date":"2026 Mar 20","pmid":"41866098","title":"The C-type lysozyme of Miichthys miiuy exhibits specific antibacterial activity against Gram-negative bacteria.","journal":"Fish & shellfish immunology"},{"date":"2026 Mar 18","pmid":"41861884","title":"Cellulose-based hydrogel SERS sensor for label-free detection and identification of antithyroid drugs.","journal":"International journal of biological macromolecules"},{"date":"2026 Jun","pmid":"41859187","title":"Optimization of an ex vivo model to test the ability of chemicals to disrupt thyroid hormone synthesis.","journal":"Toxicology reports"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"MMI","genericName":"MMI","companyName":"Xiao-Ming Mao","companyId":"xiao-ming-mao","modality":"Small molecule","firstApprovalDate":"","aiSummary":"MMI is a selective monoamine oxidase B (MAO-B) inhibitor. Used for Parkinson's disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}